covid

Antibodies against COVID-19 discovered in 82 percent of Kerala residents

Around 82 percent of those who took part in the seroprevalence survey in Kerala had antibodies in their systems that…

3 years ago

India will begin trials of two new drugs to treat Covid-19 as part of the WHO Solidarity Clinical Trials.

The WHO Solidarity PLUS experiment includes 52 nations, with India being one of them. The efficacy of another medicine, artesunate,…

3 years ago

Covid case Update: India reports 20,799 new cases, 90.79 cr doses administered till date

In the previous 24 hours, India has reported 20,799 new cases, down 8.9% from yesterday. India's overall caseload now stands…

3 years ago

Rajasthan health dept approves 886 ICU beds for children

To address the probable surge of Covid-19 cases among children during the third wave of the pandemic, the state's health department…

3 years ago

Zydus Cadila proposes Rs 1900 for three-dose COVID vaccine; Govt negotiating to bring it down

Indian pharmaceutical Zydus Cadila has suggested pricing for its three-dose Covid-19 vaccine ZyCov-D at $1,900, reported PTI. However, according to…

3 years ago

Must wait for everyone to get both doses before discussing booster, says Dr Anil Arora

“If we keep on giving boosters to those who have a controversial role in prevention of disease, we are trying…

3 years ago

India crossed landmark of 90 cr jabs, says Union Health Minister

New Delhi, India Union Health Minister Mansukh Mandaviya announced on Friday that India has reached a milestone of 90 crore…

3 years ago

Was against Covid still not easy, might come back with a vengeance, says AIIMS Covid Task Force Chief

As India has successfully administered 90 crore COVID-19 vaccine doses, Dr. Naveet Wig, Chairperson of the Covid Task Force in…

3 years ago

Ahead of Indian Festivities, AIIMS director warns of third wave in the country

In the run-up to the festivities, the director of the All India Institute of Medical Sciences (AIIMS), Randeep Guleria, has…

3 years ago

Merck’s new drug, Molnupiravir to treat Covid-19

Early findings from Phase-3 studies showed that Merck and Ridgeback Biotherapeutics' antiviral medication molnupiravir reduced the odds of hospitalisation in…

3 years ago